日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A potent inhibitor of PAI-1, MDI-2517, mitigates disease severity in a preclinical systemic sclerosis model

PAI-1 的强效抑制剂 MDI-2517 可减轻临床前系统性硬化症模型中的疾病严重程度。

Su, Enming J; Tsou, Pei-Suen; Warnock, Mark; Subbotina, Natalya; Mann, Kris; Vichaikul, Sirapa; Rosek, Alyssa; Leung, Lisa; Xing, Xianying; Xing, Enze; Plazyo, Olesya; Bogle, Rachael; Tsoi, Lam C; Emal, Cory D; Khanna, Dinesh; Varga, John; Sisson, Thomas H; Gudjonsson, Johann E; Lawrence, Daniel A

PAI-1 Inhibition in experimental venous thrombosis

PAI-1抑制剂在实验性静脉血栓形成中的作用

Shaydakov, Maxim E; Emal, Cory D; Rainey, Joshua P; Lawrence, Daniel A; Diaz, Jose A

Targeting Plasminogen Activator Inhibitor-1 with a Novel Small Molecule Inhibitor Attenuates Lung Fibrosis.

利用新型小分子抑制剂靶向纤溶酶原激活物抑制剂-1可减轻肺纤维化

Sisson Thomas H, Fortier Sean, Tsoi Lam C, Alonzo Roxann, Subbotina Natalya, Warnock Mark, Mann Kris, Gutor Sergey S, Hartman J Craig, Gudjonsson Johann E, Su Enming J, Emal Cory D, Lawrence Daniel A

Druggable Hot Spots in the Schistosomiasis Cathepsin B1 Target Identified by Functional and Binding Mode Analysis of Potent Vinyl Sulfone Inhibitors.

通过对强效乙烯砜抑制剂的功能和结合模式分析,确定了血吸虫病组织蛋白酶 B1 靶点的可成药热点

Jílková Adéla, Rubešová Petra, Fanfrlík Jindřich, Fajtová Pavla, Řezáčová Pavlína, Brynda Jiří, Lepšík Martin, Mertlíková-Kaiserová Helena, Emal Cory D, Renslo Adam R, Roush William R, Horn Martin, Caffrey Conor R, Mareš Michael

Novel bis-arylsulfonamides and aryl sulfonimides as inactivators of plasminogen activator inhibitor-1 (PAI-1)

新型双芳基磺酰胺和芳基磺酰亚胺作为纤溶酶原激活物抑制剂-1 (PAI-1) 的灭活剂

El-Ayache, Nadine C; Li, Shih-Hon; Warnock, Mark; Lawrence, Daniel A; Emal, Cory D